Skip to Main content Skip to Navigation
New interface
Journal articles

Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.

Abstract : A growing number of observations has suggested that plasmacytoid dendritic cells (pDC) play a critical role in tumor biology. In patients, infiltration of tumors by pDCs generally correlates with a poor prognosis, suggesting that pDCs may play an important role in the host-tumor relationship. Here, we analyze the influence of pDCs in solid tumor development using two different tumor models: TC-1 and B16-OVA. Phenotypic and functional gene profiling analysis of tumor-associated pDCs showed that the tumor microenvironment affected their activation status and ability to produce cytokines and chemokines. In addition, tumor cells secreted factors that inhibit the ability of pDCs to produce type I IFN. Among the various cytokines and chemokines produced by the tumor cells, we demonstrate that TGFβ is the main factor responsible for this inhibition. Using a mouse model deficient for pDCs, we also show that pDCs promote TC-1 tumor growth and that natural killer (NK) cells and regulatory T cells are involved in the protumoral effect of pDCs. Overall, our results evidence the cross-talk among pDCs, NK, and regulatory T cells in the promotion of tumor growth and their role in the development of antitumor immune responses.Significance: These findings highlight the importance of pDCs in the cross-talk between tumor cells and the immune system
Document type :
Journal articles
Complete list of metadata
Contributor : Gilles Dadaglio Connect in order to contact the contributor
Submitted on : Tuesday, December 4, 2018 - 2:52:00 PM
Last modification on : Thursday, April 7, 2022 - 10:10:25 AM


Files produced by the author(s)


Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike 4.0 International License



Mariana Terra, Marine Oberkampf, Catherine Fayolle, Pierre Rosenbaum, Camille Guillerey, et al.. Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.. Cancer Research, 2018, 78 (11), pp.3014-3026. ⟨10.1158/0008-5472.CAN-17-2719⟩. ⟨pasteur-01942405⟩



Record views


Files downloads